IOL Chemicals and Pharmaceuticals Limited, a key player in the production of both pharmaceuticals and specialty chemicals, has made a major move by appointing Vikas Vij as its new Chief Executive Officer. With over 30 years of experience in the pharma industry, including top leadership positions at well-respected companies such as Cipla, Ranbaxy, and Alembic Pharmaceuticals, Vij brings a wealth of expertise and industry knowledge to the role.
On his appointment, Vij said, “I’m eager to join the talented team at IOL and help drive the company’s next phase of growth. It’s a true honor to lead a company that is making such a positive impact on people’s lives and on the Indian Pharmaceutical Industry.”
Joint Managing Director of IOL Chemicals and Pharmaceuticals, Vikas Gupta, expressed his excitement about the appointment, saying, “We’re thrilled to welcome Vikas Vij as CEO of IOL Chemicals and Pharmaceuticals. With his exceptional skills and experience, we’re confident that he will take the company to new heights, both in India and in other markets. His deep understanding of the pharma value chain, including Active Pharmaceutical Ingredients (API), Finished Dosage Forms (FDF), and Custom Pharmaceutical Services (CRAMS), will be instrumental in driving portfolio enhancement and operational efficiencies for IOL.”